Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Doctors Say Teen's HIV in Check for 12 Years without Drugs

July 21, 2015 8:19 am | by Marilynn Marchione, AP Medical Writer | News | Comments

An 18-year-old French teen born with the AIDS virus has had her infection under control and nearly undetectable despite stopping treatment 12 years ago - an unprecedented remission. Read more...

TOPICS:

Scientists Find New Variant of Streptococcal Bacteria Causing Severe Infections

July 21, 2015 8:18 am | by Imperial College London | News | Comments

Japan, Canada, France and Sweden have reported a surge in the same strain type, raising the possibility that the new variant is spreading globally. Read more...

TOPICS:

FDA Approves Novo Nordisk's Treatment for Growth Hormone Related Disorders

July 21, 2015 8:18 am | News | Comments

Norditropin FlexPro is the only prefilled growth hormone injection pen that can be stored outside of the refrigerator for up to 21 days after first use. Read more...

TOPICS:
Advertisement

Possibility of Predicting Alzheimer’s With Saliva Test

July 20, 2015 1:14 pm | by Stephanie Guzowski, Editor | News | Comments

Could a saliva test help determine if someone has Alzheimer’s disease? Although the research is very preliminary, scientists say they have pinpointed a series of chemical compounds in saliva that can differentiate between people with normal aging, those with mild cognitive impairment (MCI), and Alzheimer’s disease. Read more...

TOPICS:

Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma

July 20, 2015 11:48 am | by National Cancer Institute | News | Comments

A clinical trial has shown that patients with a specific molecular subtype of diffuse large B-cell lymphoma (DLBCL) are more likely to respond to the drug ibrutinib (Imbruvica) than patients with another molecular subtype of the disease. Read more...

TOPICS:

Life-Saving Breast Cancer Drugs Going Untaken in Appalachia

July 20, 2015 10:54 am | by University of Virginia Health System | News | Comments

Nearly a third of breast cancer survivors in Appalachia are not taking the critical, potentially life-saving follow-up treatment – despite having insurance that would pay for it, a troubling new study has found. Read more...

TOPICS:

New Findings Hint Toward Reversing Hearing Loss

July 20, 2015 10:43 am | by Washington University in St. Louis | News | Comments

Unlike birds and amphibians, mammals can’t recover lost hearing. In people, the cells of the inner ear responsible for detecting sound and transmitting those signals to the brain form during early stages of development and can’t be replaced if lost due to illness, injury or aging. Read more...

TOPICS:

TSRI Receives $2.8 Million to Develop Approach to Latent HIV Infection

July 20, 2015 10:36 am | by The Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded a pair of grants totaling nearly $2.8 million from the National Institute of Allergy and Infectious Diseases of The National Institutes of Health to develop a new therapeutic agent to reduce latent levels of HIV that hide from the immune system in infected individuals. Read more..

TOPICS:
Advertisement

California Universities Battle Over Alzheimer's Research

July 20, 2015 10:27 am | by Associated Press | News | Comments

One university's effort to poach a star faculty member at another Southern California university has devolved into a legal battle that some fear may impede Alzheimer's disease research. Read more...

TOPICS:

Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs

July 20, 2015 9:40 am | by University of Aberdeen | News | Comments

A crucial 'on switch' that boosts the body's defences against infections has been successfully identified in new scientific research. Read more...

TOPICS:

DelMar Expands GBM Clinical Trial with 5th Site in Denver

July 20, 2015 9:34 am | News | Comments

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, today announced that the Sarah Cannon Cancer Research Center at HealthOne, Denver, CO has been added as a clinical trial site for the ongoing, multicenter Phase I/II study of VAL-083 in patients with GBM. Read more...

TOPICS:

Roche Expands HIV Global Access Program

July 20, 2015 9:30 am | News | Comments

Roche announced today an expansion to the HIV Global Access Program to include early infant HIV diagnostic testing for low and middle income countries. Read more...

TOPICS:

Diabetes, Cardiovascular Link Often Overlooked

July 20, 2015 8:50 am | by University of Queensland | News | Comments

The program continues to support people in Australia with Type 1 and Type 2 diabetes. Read more...

TOPICS:

Valeant Agrees to Acquire Amoun Pharmaceuticals

July 20, 2015 8:43 am | News | Comments

Valeant intends for Amoun to serve as a platform for further expansion in the broader Middle East and North Africa pharmaceutical market and expects the transaction to close in the third quarter. Read more...

TOPICS:

Liberia Says 4 Remaining Ebola Patients Have Recovered

July 20, 2015 8:38 am | by Jonathan Paye-Layleh, Associated Press | News | Comments

The four remaining patients infected during Liberia's recent string of Ebola cases have recovered, meaning there are currently no confirmed cases in the country though more than 100 people are still under surveillance, a health official said Friday. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading